Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Genome sequence of multidrug-resistant Erysipelothrix rhusiopathiae ZJ carrying several acquired antimicrobial resistance genes.

Gu J, Li YX, Xu CW, Xie XJ, Li P, Ma GX, Lei CW, Liu JX, Zhang AY.

J Glob Antimicrob Resist. 2020 Feb 28;21:13-15. doi: 10.1016/j.jgar.2020.02.017. [Epub ahead of print]

2.

A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib.

Chen HF, Wang WX, Xu CW, Huang LC, Li XF, Lan G, Zhai ZQ, Zhu YC, Du KQ, Lei L, Fang MY.

Lung Cancer. 2020 Apr;142:59-62. doi: 10.1016/j.lungcan.2020.02.012. Epub 2020 Feb 21.

PMID:
32114282
3.

Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China.

Chen YP, Ke LF, Lu JP, Wang JC, Zhu WF, Chen FF, Lin SF, Xu CW, Wu MJ, Chen G.

Onco Targets Ther. 2019 Nov 26;12:10165-10175. doi: 10.2147/OTT.S222189. eCollection 2019.

4.

[Clinical and electrophysiological features and treatment of acrylamide-induced toxic peripheral neuropathy].

Xu CW, Wu HF, Chen J.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Jan 20;38(1):45-47. doi: 10.3760/cma.j.issn.1001-9391.2020.01.010. Chinese.

PMID:
32062896
5.

Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report.

Chen HF, Wang WX, Li XF, Wu LX, Zhu YC, Du KQ, Xu CW.

World J Clin Cases. 2020 Jan 26;8(2):410-414. doi: 10.12998/wjcc.v8.i2.410.

6.

An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.

Yang ZY, Yang L, Xu CW, Wang XJ, Lei L.

Biol Open. 2020 Jan 24;9(1). pii: bio047662. doi: 10.1242/bio.047662.

7.

Investigation on glucocorticoid receptors within platelets from adult patients with immune thrombocytopenia.

Yung KC, Xu CW, Zhang ZW, Yu WJ, Li Q, Xu XR, Han YF, Wang XJ, Yin J.

Hematology. 2020 Dec;25(1):37-42. doi: 10.1080/16078454.2019.1710025.

PMID:
31905108
8.

A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations.

Lei L, Wang WX, Yu ZY, Liang XB, Pan WW, Chen HF, Wang LP, Fang Y, Wang M, Xu CW, Fang MY.

Transl Oncol. 2020 Feb;13(2):329-335. doi: 10.1016/j.tranon.2019.12.004. Epub 2019 Dec 24.

9.

Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.

Lei L, Wang WX, Zhu YC, Li JL, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Fang MY, Xu CW, Wang XJ, Lv TF, Song Y.

Cancer Sci. 2020 Feb;111(2):679-686. doi: 10.1111/cas.14277. Epub 2020 Jan 16.

10.

SEPT7 Interacts with KIF20A and Regulates the Proliferative State of Neural Progenitor Cells During Cortical Development.

Qiu R, Runxiang Q, Geng A, Liu J, Xu CW, Menon MB, Gaestel M, Lu Q.

Cereb Cortex. 2019 Dec 9. pii: bhz292. doi: 10.1093/cercor/bhz292. [Epub ahead of print]

PMID:
31813992
11.

Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma.

Zhu YC, Xu CW, Zhang QX, Wang WX, Lei L, Zhuang W.

Chin Med J (Engl). 2019 Dec 20;132(24):3015-3017. doi: 10.1097/CM9.0000000000000555. No abstract available.

12.

Influence of lncRNA ANRIL on neuronal apoptosis in rats with cerebral infarction by regulating the NF-κB signaling pathway.

Zhao JH, Wang B, Wang XH, Wang JR, Xu CW.

Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):10092-10100. doi: 10.26355/eurrev_201911_19577.

13.

Effect of lncRNA GAS5 on the apoptosis of neurons via the notch1 signaling pathway in rats with cerebral infarction.

Zhao JH, Wang B, Wang XH, Xu CW.

Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):10083-10091. doi: 10.26355/eurrev_201911_19576.

14.

Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.

Zhang JT, Li Y, Yan LX, Zhu ZF, Dong XR, Chu Q, Wu L, Zhang HM, Xu CW, Lin G, Yu ZY, Hu J, Zhu B, Wang HJ, Yang F, Song ZB, Han ZB, Li MX, Lin J, Wu YL, Wang JL, Zhong WZ.

Lung Cancer. 2020 Jan;139:118-123. doi: 10.1016/j.lungcan.2019.11.004. Epub 2019 Nov 11.

15.

Isolation of virulent phages infecting dominant mesophilic aerobic bacteria in cucumber pickle fermentation.

Zheng XF, Yang ZQ, Zhang H, Jin WX, Xu CW, Gao L, Rao SQ, Jiao XA.

Food Microbiol. 2020 Apr;86:103330. doi: 10.1016/j.fm.2019.103330. Epub 2019 Sep 11.

PMID:
31703878
16.

Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.

Lei L, Wang WX, Zhu YC, Li JL, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Fang MY, Xu CW, Wang XJ, Lv TF, Song Y.

Cancer Med. 2020 Jan;9(1):12-18. doi: 10.1002/cam4.2652. Epub 2019 Nov 6.

17.

Matrine suppression of self-renewal was dependent on regulation of LIN28A/Let-7 pathway in breast cancer stem cells.

Li X, Liang T, Chen SS, Wang M, Wang R, Li K, Wang JC, Xu CW, Du N, Qin S, Ren H.

J Cell Biochem. 2020 Mar;121(3):2139-2149. doi: 10.1002/jcb.29396. Epub 2019 Oct 8.

PMID:
31595560
18.

Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors.

Chen HF, Wang WX, Li XL, Xu CW, Du KQ, Zhu YC, Fang MY.

J Thorac Oncol. 2019 Oct;14(10):e217-e219. doi: 10.1016/j.jtho.2019.04.032. No abstract available.

PMID:
31558230
19.

Identification of a Novel Icotinib-Sensitive EGFR-SEPTIN14 Fusion Variant in Lung Adenocarcinoma by Next-Generation Sequencing.

Zhu YC, Wang WX, Li XL, Xu CW, Chen G, Zhuang W, Lv T, Song Y.

J Thorac Oncol. 2019 Aug;14(8):e181-e183. doi: 10.1016/j.jtho.2019.03.031. No abstract available.

PMID:
31345345
20.

MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.

Yu WC, Chen HH, Qu YY, Xu CW, Yang C, Liu Y.

Biosci Rep. 2019 Jul 10;39(7). pii: BSR20190198. doi: 10.1042/BSR20190198. Print 2019 Jul 31.

21.

Long noncoding RNA PVT1-214 enhances gastric cancer progression by upregulating TrkC expression in competitively sponging way.

Zhao S, Fan NF, Chen XH, Zhuo CH, Xu CW, Lin RB.

Eur Rev Med Pharmacol Sci. 2019 May;23(10):4173-4184. doi: 10.26355/eurrev_201905_17920.

22.

Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Huang ZZ, Du KQ.

Cell Mol Biol (Noisy-le-grand). 2019 Apr 30;65(4):48-52.

PMID:
31078152
23.

[Diffusion tensor imaging and visual evoked potentials in pediatric patients with sellar region lesions].

Luo B, Miao SH, He L, Zhao YP, Xu CW, Zhu J, Zhang QH, Liu W, Ma Y, Zhang YQ.

Zhonghua Yi Xue Za Zhi. 2019 Apr 16;99(15):1167-1171. doi: 10.3760/cma.j.issn.0376-2491.2019.15.010. Chinese.

PMID:
31006221
24.

A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib.

Zhu YC, Wang WX, Xu CW, Zhuang W, Du KQ, Chen G, Lv TF, Song Y.

Clin Lung Cancer. 2019 May;20(3):e224-e228. doi: 10.1016/j.cllc.2019.02.020. Epub 2019 Mar 4. No abstract available.

PMID:
30914311
25.

Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer.

Zhu YC, Zhang XG, Lin XP, Wang WX, Li XF, Wu LX, Chen HF, Xu CW, Du KQ.

Oncol Lett. 2019 Mar;17(3):3466-3474. doi: 10.3892/ol.2019.9949. Epub 2019 Jan 18.

26.

Nutlin-3-Induced Sensitization of Non-Small Cell Lung Cancer Stem Cells to Axitinib-Induced Apoptosis Through Repression of Akt1/Wnt Signaling.

Wang M, Wang X, Li Y, Xiao Q, Cui XH, Xiao GD, Wang JC, Xu CW, Ren H, Liu D.

Oncol Res. 2019 Sep 23;27(9):987-995. doi: 10.3727/096504018X15424918479652. Epub 2019 Mar 4.

PMID:
30832755
27.

Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.

Wu LX, Li XF, Chen HF, Zhu YC, Wang WX, Xu CW, Xie DF, Wan Y, Du KQ.

Cell Mol Biol (Noisy-le-grand). 2018 Dec 31;64(15):67-70.

PMID:
30672447
28.

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib.

Chen HF, Zhang QX, Zhu YC, Du KQ, Li XF, Wu LX, Wang WX, Xu CW.

Onco Targets Ther. 2018 Nov 5;11:7821-7825. doi: 10.2147/OTT.S178985. eCollection 2018.

29.

A meta-analysis of association between serum iron levels and lung cancer risk.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Xie DF, Huang JH, Du KQ.

Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):33-37.

PMID:
30403607
30.

Study on the Role of Calreticulin Within Platelet from Adult Patients with Chronic Immune Thrombocytopenic Purpura.

Yung KC, Zhang ZW, Yu WJ, Qiu JF, Xu CW, He CL, Xu XR, Yin J.

Indian J Hematol Blood Transfus. 2018 Oct;34(4):711-718. doi: 10.1007/s12288-018-0955-8. Epub 2018 Apr 2.

31.

The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma.

Zhu YC, Wang WX, Zhang QX, Xu CW, Zhuang W, Du KQ, Chen G, Lv TF, Song Y.

Clin Lung Cancer. 2019 Jan;20(1):e73-e76. doi: 10.1016/j.cllc.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30366769
32.

Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing.

Zhu YC, Wang WX, Xu CW, Zhang QX, Du KQ, Chen G, Lv TF, Song Y.

Ann Oncol. 2018 Dec 1;29(12):2392-2393. doi: 10.1093/annonc/mdy455. No abstract available.

33.

H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells.

Wang M, Li Y, Xiao GD, Zheng XQ, Wang JC, Xu CW, Qin S, Ren H, Tang SC, Sun X.

Cell Prolif. 2019 Jan;52(1):e12534. doi: 10.1111/cpr.12534. Epub 2018 Oct 18.

34.

MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma.

Zhu YC, Wang WX, Song ZB, Zhang QX, Xu CW, Chen G, Zhuang W, Lv T, Song Y.

J Thorac Oncol. 2018 Oct;13(10):e202-e204. doi: 10.1016/j.jtho.2018.05.009. No abstract available.

35.

Association between BIM polymorphism and lung cancer outcomes: a meta-analysis.

Li XF, Wu LX, Chen HF, Zhu YC, Wang WX, Xu CW, Lin XP, Xie DF, Du KQ.

Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):92-96.

PMID:
30213299
36.

MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).

Zheng XM, Xu CW, Wang F.

Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):31-35.

PMID:
30213286
37.

Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.

Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.

Biochem Biophys Res Commun. 2018 Oct 2;504(2):491-498. doi: 10.1016/j.bbrc.2018.08.193. Epub 2018 Sep 6.

PMID:
30197002
38.

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib.

Zhu YC, Wang WX, Xu CW, Zhuang W, Song ZB, Du KQ, Chen G, Lv TF, Song Y.

Cancer Biol Ther. 2018;19(12):1097-1101. doi: 10.1080/15384047.2018.1491506. Epub 2018 Aug 10.

39.

Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib.

Zhu YC, Wang WX, Xu CW, Tan QH, Li JY, Zhuang W, Song ZB, Du KQ, Chen G, Lv TF, Song Y.

J Thorac Dis. 2018 May;10(5):E359-E363. doi: 10.21037/jtd.2018.04.162. No abstract available.

40.

TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib.

Wang WX, Xu CW, Chen YP, Liu W, Zhong LH, Chen FF, Zhuang W, Huang YJ, Huang ZZ, Chen RR, Guan YF, Yi X, Lv TF, Zhu WF, Lu JP, Wang XJ, Shi Y, Lin XD, Chen G, Song Y.

J Thorac Dis. 2018 May;10(5):2991-2998. doi: 10.21037/jtd.2018.04.98.

41.

The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.

Li XY, Su L, Jiang YM, Gao WB, Xu CW, Zeng CQ, Song J, Xu Y, Weng WC, Liang WB.

Evid Based Complement Alternat Med. 2018 Apr 23;2018:6714829. doi: 10.1155/2018/6714829. eCollection 2018.

42.

Lung adenocarcinoma patient with EGFR 19 exon insert mutation and its response to icotinib.

Zhu YC, Du KQ, Wang WX, Song ZB, Xu CW, Chen G, Zhuang W, Lv TF, Song Y.

Lung Cancer. 2018 Jul;121:101-104. doi: 10.1016/j.lungcan.2018.04.019. Epub 2018 Apr 24. No abstract available.

PMID:
29773459
43.

Clonally-related primary ALK rearranged adenocarcinoma and associated metastatic lesions.

Zhu YC, Deng YT, Wang WX, Xu CW, Zhuang W, Du KQ.

Thorac Cancer. 2018 Jul;9(7):881-884. doi: 10.1111/1759-7714.12648. Epub 2018 May 8.

44.

[The application of stereo-electroencephalography guided radiofrequency thermocoagulation in refractory temporal epilepsy].

Xu CW, Zhou WJ, Bai JJ, Zhang BQ, Wang HX, Ruan J, Li J, Lin JL, Zhang YQ.

Zhonghua Yi Xue Za Zhi. 2018 Apr 3;98(13):1008-1012. doi: 10.3760/cma.j.issn.0376-2491.2018.13.011. Chinese.

PMID:
29690711
45.

Dr. Philippe E. Spiess: right treatments offer patients best chance of cure.

Ma L, Liu AY, Xu CW, Zhou SL.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S154-S156. doi: 10.21037/tau.2018.01.13. No abstract available.

46.

Prof. Steven Patierno: perseverance, creativity and collaboration are the keys to successful research.

Li B, Xu CW, Zhou SL.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S151-S153. doi: 10.21037/tau.2018.01.10. No abstract available.

47.

Dr. Run Wang: penile implant as the first line treatment for severe erectile dysfunction.

Poon B, Wu M, Xu CW, Zhou SL.

Transl Androl Urol. 2018 Mar;7(Suppl 1):S147-S150. doi: 10.21037/tau.2018.01.09. No abstract available.

48.

Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib.

Xu CW, Wang WX, Chen YP, Chen Y, Liu W, Zhong LH, Chen FF, Zhuang W, Song ZB, Chen XH, Huang YJ, Guan YF, Yi X, Lv TF, Zhu WF, Lu JP, Wang XJ, Shi Y, Lin XD, Chen G, Song Y.

J Transl Med. 2018 Apr 11;16(1):93. doi: 10.1186/s12967-018-1468-9.

49.

CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.

Zhu YC, Zhou YF, Wang WX, Xu CW, Zhuang W, Du KQ, Chen G.

Thorac Cancer. 2018 May;9(5):652-655. doi: 10.1111/1759-7714.12617. Epub 2018 Mar 8.

50.

Preliminary investigation about the expression of tubulin in platelets from patients with iron deficiency anemia and thrombocytosis.

Yung KC, Zhang ZW, Yu WJ, Qiu JF, Xu CW, He CL, Xu XR, Yin J.

Hematology. 2018 Sep;23(8):549-557. doi: 10.1080/10245332.2018.1439679. Epub 2018 Mar 2.

PMID:
29499633

Supplemental Content

Support Center